Innate control of the inflammatory process during fungal infections
真菌感染期间炎症过程的先天控制
基本信息
- 批准号:10641775
- 负责人:
- 金额:$ 51.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAffectAllergic DiseaseAnatomyAntibodiesAntibody FormationAntifungal AgentsAntigensAttentionAutoimmune DiseasesB-LymphocytesBindingBypassC Type Lectin ReceptorsCandidaCandida albicansCandidiasisCell WallCellsCenters for Disease Control and Prevention (U.S.)DataDetectionDevelopmentDiseaseEpitheliumEventGene MutationGenetic TranscriptionGoalsHealthImmuneImmune responseImmune systemImmunocompromised HostImmunologyIncidenceIndividualInfectionInfectious AgentInflammationInflammatoryInnate Immune ResponseInnate Immune SystemInterferon Type IIInterferonsLifeLigandsLocationLymph Node Subcapsular SinusMacrophageMediatingMedicalModelingModernizationMycosesNF-kappa BOutcomePathway interactionsPatientsPattern recognition receptorPeripheralPersonsPhagocytesPolysaccharidesPredispositionProcessProductionRoleSentinelSepsisSignal TransductionSolubilityStimulusTestingTherapeuticTherapeutic InterventionTimeTissuesVaccinesadaptive immune responseadaptive immunityautoimmune pathogenesiscandidemiadesigndraining lymph nodefungusgenetic signatureglobal healthimprovedinflammatory milieuinnovationinsightmicrobialmigrationnovelnovel therapeutic interventionpathogenphysical propertypreventprotein functionrelB proteinresponsetherapeutically effective
项目摘要
PROJECT SUMMARY
The dialogue between innate and adaptive branches of the immune system is a central paradigm of modern
immunology and is vital for protection against infections as well as for the pathogenesis of autoimmune, allergic
and inflammatory diseases. According to the current model, innate immune sentinels dispersed throughout
peripheral tissues sense, via their pattern recognition receptors (PRRs), the presence of microbial clues or
endogenous moieties released during an infection, are activated and migrate to the draining lymph node (dLN).
This process enables a transfer of “information” from peripheral tissue to the dLN, where the antigen-dependent
adaptive immune response against the pathogen is initiated. The dLN also hosts an initial antigen-independent,
innate immune response governed by migrating phagocytes that enables expansion of the LN and establishes
a pro-inflammatory milieu. These events are required for the development and polarization of the adaptive
immune response. Here, we focused our attention on the capacity of ligands derived from the cell wall of Candida
(C.) albicans to dictate the LN innate response. Our working hypothesis is that the size and solubility of
stimuli that activate the PRRs affect not only the LN innate response itself, but also the final outcome of
the immune response. Also, that the LN innate response initiated by soluble fungal ligands can be
harnessed to develop a potent and protective adaptive immune response to prevent life-threatening
systemic fungal infections. Our preliminary data demonstrate that the physical form of fungal ligands dictates
the location where the initial immune response takes place, and thereby determines the activation of adaptive
immunity. In particular, we have found that small soluble fungal ligands that are immunosilent in the periphery
and do not cause an inflammation in the tissue, become potent immunogens once they reach the dLN. Also, that
the LN innate response initiated by these ligands completely bypasses the need of phagocyte migration from the
periphery into the dLN and, instead, requires a unique gene signature that is characterized by the production of
interferons and that is driven by the activation of the noncanonical NFkB transcription factor RelB in subcapsular
sinus macrophages. Notably, Dectins are required for this process but CARD9, the key signaling adaptor
downstream of Dectins, is largely dispensable. Plus, the initial innate response to the dLN instructs a potent
type 1 adaptive immunity and allows the production of antibodies directed against the most external layer of the
fungal cell wall. Fungal diseases are a global health problem and Candida species are the most common cause
of invasive fungal infections. We propose to unravel how physical properties of the PAMPs can be harnessed as
a therapeutic intervention against systemic fungal infections that are a major medical problem in the US. We
anticipate that identifying new features of the immune response that is anatomically restricted to the LN will help
with the design of an improved vaccine against poorly controlled pathogens.
项目摘要
免疫系统的先天和适应性分支之间的对话是现代的中心范式
免疫学对于防御感染以及自身免疫性过敏性的发病机理至关重要
和炎症性疾病。根据当前的模型,先天免疫哨兵分散了
外围组织通过其模式识别受体(PRR),微生物线索或
感染期间释放的内源性部分被激活,并迁移到排水淋巴结(DLN)。
该过程使“信息”从外围组织转移到DLN,抗原依赖性
启动针对病原体的自适应免疫反应。 DLN还托管一个初始抗原独立的,
先天免疫反应由迁移的吞噬细胞迁移,该吞噬细胞能够扩展LN并建立
亲炎的环境。这些事件是自适应发展和两极分化所必需的
免疫反应。在这里,我们将注意力集中在源自念珠菌细胞壁的配体能力上
(C.)白色疾病决定LN先天反应。我们的工作假设是
激活PRR的刺激不仅会影响LN先天反应本身,还会影响
免疫反应。此外,坚固真菌配体发起的LN先天反应可以是
利用以发展潜在和受保护的适应性免疫反应以防止威胁生命
系统性真菌感染。我们的初步数据表明,真菌配体的物理形式决定了
初始免疫反应发生的位置,从而确定适应性的激活
免疫。特别是,我们发现在周围免疫的小固体真菌配体
并且不会在组织中注射注射,一旦到达DLN,就会成为潜在的免疫原子。另外,
这些配体发起的LN先天反应完全绕过了对吞噬细胞迁移的需求
外围进入DLN,相反,需要一个独特的基因特征,其特征是产生
干扰素,这是由亚囊中非规范NFKB转录因子RELB的激活所驱动的
鼻窦巨噬细胞。值得注意的是,此过程需要Dectin,但Card9是关键信号适配器
下游的dectins基本上是可分配的。另外,最初对DLN的先天反应指示有效
1型自适应免疫,并允许针对最外层的抗体产生
真菌细胞壁。真菌疾病是全球健康问题,念珠菌物种是最常见的原因
侵入性真菌感染。我们建议解散如何将弹丸的物理特性当作
在美国,是针对全身真菌感染的治疗干预措施。我们
预计确定在解剖学上仅限于LN的免疫响应的新功能将有所帮助
通过针对无法控制的病原体进行改进的疫苗设计。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay.
医学中的微生物组研究以及更密切的多学科相互作用的需要。
- DOI:10.1126/scisignal.aba9911
- 发表时间:2020
- 期刊:
- 影响因子:7.3
- 作者:Mancini,Nicasio;Peri,Francesco;Rescigno,Maria;Zanoni,Ivan
- 通讯作者:Zanoni,Ivan
μMAPPS: a novel phasor approach to second harmonic analysis for in vitro-in vivo investigation of collagen microstructure.
- DOI:10.1038/s41598-017-17726-y
- 发表时间:2017-12-12
- 期刊:
- 影响因子:4.6
- 作者:Radaelli F;D'Alfonso L;Collini M;Mingozzi F;Marongiu L;Granucci F;Zanoni I;Chirico G;Sironi L
- 通讯作者:Sironi L
Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases.
- DOI:10.3389/fcimb.2021.808005
- 发表时间:2021
- 期刊:
- 影响因子:5.7
- 作者:Stefanetti G;Borriello F;Richichi B;Zanoni I;Lay L
- 通讯作者:Lay L
Editorial: Interferon-λs: New Regulators of Inflammatory Processes.
社论:干扰素:炎症过程的新调节器。
- DOI:10.3389/fimmu.2019.02117
- 发表时间:2019
- 期刊:
- 影响因子:7.3
- 作者:Zanoni,Ivan;Odendall,Charlotte
- 通讯作者:Odendall,Charlotte
Cellular and molecular mechanisms of antifungal innate immunity at epithelial barriers: The role of C-type lectin receptors.
- DOI:10.1002/eji.201848054
- 发表时间:2020-03
- 期刊:
- 影响因子:5.4
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivan Zanoni其他文献
Ivan Zanoni的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivan Zanoni', 18)}}的其他基金
Macrophage immunometabolism controls septic shock
巨噬细胞免疫代谢控制感染性休克
- 批准号:
10658162 - 财政年份:2023
- 资助金额:
$ 51.38万 - 项目类别:
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
通过调节真菌甘露聚糖的物理特性开发新型佐剂策略
- 批准号:
10338399 - 财政年份:2021
- 资助金额:
$ 51.38万 - 项目类别:
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
通过调节真菌甘露聚糖的物理特性开发新型佐剂策略
- 批准号:
10490881 - 财政年份:2021
- 资助金额:
$ 51.38万 - 项目类别:
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
通过调节真菌甘露聚糖的物理特性开发新型佐剂策略
- 批准号:
10687182 - 财政年份:2021
- 资助金额:
$ 51.38万 - 项目类别:
Innate control of the inflammatory process during fungal infections
真菌感染期间炎症过程的先天控制
- 批准号:
10293993 - 财政年份:2016
- 资助金额:
$ 51.38万 - 项目类别:
Innate control of the inflammatory process during fungal infections
真菌感染期间炎症过程的先天控制
- 批准号:
10434924 - 财政年份:2016
- 资助金额:
$ 51.38万 - 项目类别:
Innate control of the inflammatory process during fungal infections
真菌感染期间炎症过程的先天控制
- 批准号:
9122779 - 财政年份:2016
- 资助金额:
$ 51.38万 - 项目类别:
Innate control of the inflammatory process during fungal infections
真菌感染期间炎症过程的先天控制
- 批准号:
9232989 - 财政年份:2016
- 资助金额:
$ 51.38万 - 项目类别:
相似国自然基金
Long-TSLP和Short-TSLP佐剂对新冠重组蛋白疫苗免疫应答的影响与作用机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
Long-TSLP和Short-TSLP佐剂对新冠重组蛋白疫苗免疫应答的影响与作用机制
- 批准号:32170937
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
新疆一枝蒿多糖佐剂影响DCs调控Th1/Th2免疫应答的重要机制
- 批准号:31960164
- 批准年份:2019
- 资助金额:40 万元
- 项目类别:地区科学基金项目
草甘膦除草剂中佐剂对大豆根际土壤微生物群落的影响及其机制研究
- 批准号:31870495
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
亚细胞环境响应性的纳米材料与TLR激动剂复合制剂对疫苗免疫原性的影响
- 批准号:31600812
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 51.38万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 51.38万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 51.38万 - 项目类别:
Cellular mechanisms for the degeneration and aging of human rotator cuff tears
人类肩袖撕裂变性和衰老的细胞机制
- 批准号:
10648672 - 财政年份:2023
- 资助金额:
$ 51.38万 - 项目类别:
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
- 批准号:
10856753 - 财政年份:2023
- 资助金额:
$ 51.38万 - 项目类别: